Biomaterials and nanomedicine for bone regeneration: Progress and future prospects
Abstract Bone defects pose a heavy burden on patients, orthopedic surgeons, and public health resources. Various pathological conditions cause bone defects including trauma, tumors, inflammation, osteoporosis, and so forth. Auto‐ and allograft transplantation have been developed as the most commonly used clinic treatment methods, among which autologous bone grafts are the golden standard. Yet the repair of bone defects, especially large‐volume defects in the geriatric population or those complicated with systemic disease, is still a challenge for regenerative medicine from the clinical perspective. The fast development of biomaterials and nanomedicine favors the emergence and promotion of efficient bone regeneration therapies. In this review, we briefly summarize the progress of novel biomaterial and nanomedical approaches to bone regeneration and then discuss the current challenges that still hinder their clinical applications in treating bone defects..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:1 |
|---|---|
| Enthalten in: |
Exploration - 1(2021), 2, Seite n/a-n/a |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Jun Zhou [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Biomaterials |
|---|
| doi: |
10.1002/EXP.20210011 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ027672158 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ027672158 | ||
| 003 | DE-627 | ||
| 005 | 20230307115915.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/EXP.20210011 |2 doi | |
| 035 | |a (DE-627)DOAJ027672158 | ||
| 035 | |a (DE-599)DOAJb1c6241f050d40808c5d178b4a504bac | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a TP248.13-248.65 | |
| 100 | 0 | |a Jun Zhou |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Biomaterials and nanomedicine for bone regeneration: Progress and future prospects |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Bone defects pose a heavy burden on patients, orthopedic surgeons, and public health resources. Various pathological conditions cause bone defects including trauma, tumors, inflammation, osteoporosis, and so forth. Auto‐ and allograft transplantation have been developed as the most commonly used clinic treatment methods, among which autologous bone grafts are the golden standard. Yet the repair of bone defects, especially large‐volume defects in the geriatric population or those complicated with systemic disease, is still a challenge for regenerative medicine from the clinical perspective. The fast development of biomaterials and nanomedicine favors the emergence and promotion of efficient bone regeneration therapies. In this review, we briefly summarize the progress of novel biomaterial and nanomedical approaches to bone regeneration and then discuss the current challenges that still hinder their clinical applications in treating bone defects. | ||
| 650 | 4 | |a biomaterials | |
| 650 | 4 | |a bone defects | |
| 650 | 4 | |a nanomedicine | |
| 650 | 4 | |a scaffolds | |
| 650 | 4 | |a tissue engineering | |
| 653 | 0 | |a Biotechnology | |
| 700 | 0 | |a Zhongyang Zhang |e verfasserin |4 aut | |
| 700 | 0 | |a John Joseph |e verfasserin |4 aut | |
| 700 | 0 | |a Xingcai Zhang |e verfasserin |4 aut | |
| 700 | 0 | |a Bijan Emiliano Ferdows |e verfasserin |4 aut | |
| 700 | 0 | |a Dylan Neal Patel |e verfasserin |4 aut | |
| 700 | 0 | |a Wei Chen |e verfasserin |4 aut | |
| 700 | 0 | |a Giuseppe Banfi |e verfasserin |4 aut | |
| 700 | 0 | |a Roberto Molinaro |e verfasserin |4 aut | |
| 700 | 0 | |a Donato Cosco |e verfasserin |4 aut | |
| 700 | 0 | |a Na Kong |e verfasserin |4 aut | |
| 700 | 0 | |a Nitin Joshi |e verfasserin |4 aut | |
| 700 | 0 | |a Omid C. Farokhzad |e verfasserin |4 aut | |
| 700 | 0 | |a Claudia Corbo |e verfasserin |4 aut | |
| 700 | 0 | |a Wei Tao |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Exploration |d Wiley, 2021 |g 1(2021), 2, Seite n/a-n/a |w (DE-627)DOAJ078623111 |x 27662098 |7 nnns |
| 773 | 1 | 8 | |g volume:1 |g year:2021 |g number:2 |g pages:n/a-n/a |
| 856 | 4 | 0 | |u https://doi.org/10.1002/EXP.20210011 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/b1c6241f050d40808c5d178b4a504bac |z kostenfrei |
| 856 | 4 | 0 | |u https://doi.org/10.1002/EXP.20210011 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2766-8509 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2766-2098 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 1 |j 2021 |e 2 |h n/a-n/a | ||